Bactriology Lecture 3 Wk7 Flashcards

1
Q

Evolutionary timetable

A

Rise of oxygen stimulates rise of diverse range of living organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

rRNA sequence - phylogenetic analysis

A

Bacteria -
Archaea
Eukarya

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bacterial evolutionary marker - ribosomal RNA

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

E. Coli 16s rRNA

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

16s rRNA gene amplification, sequencing

A

Cell culture -> DNA extract and PCR -> electrophoresis (check 16s DNA) -> sequencing -> align sequences, create phylogenetic tree.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Internal nodes - ancestor species
External nodes - extant known species

A

Branch - lengths represent evolutionary distance between species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Systematics, phylogeny and taxonomy

A

Systematics or phylogeny= study of evolutionary history of organisms
Taxonomy = science of classification to show similarities among organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Traditional taxonomy = practical aspects, visible properties
Modern taxonomy = DNA sequences + practical aspects

A

Modern bacterial taxonomy by polyphasic approach
1. Phenotypic 2. Genotypes 3. Phylogenetic
Petri dish. DNA. Tree

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Biochemical test to separate bacterial species

A

Gram staining
Lactose fermentation
Oxidase
Catalase
Slide agglutination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fatty acid analysis
Bacterial culture
Extract fatty acids
Derivatize to form methyl esters
Gas chromatography
Peaks from various fatty acid methyl esters
Compare pattern with database
Identify organism

A

Classes in bacteria
I. Saturated
II. Unsaturated
III. Cyclopropane
IV. Branched
V. Hydroxy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Genotype

A

GC content (%) = G+C/A+T+G+C X 100

GC-ratio= A+T/ G+C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bacterial taxonomy y- genotype

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Taxonomic Classification + nomenclature
- bacterial taxonomic hierarchy

A

Escherichia coli Staphylococcus aureus Streptomyces coelicolor

Domain Bacteria Bacteria Bacteria
Phylum Proteobacteria Firmicutes Actinobacteria
Class Gammaproteobacteria Bacilli Actinobacteria
Order Enterobacteriales Bacillales Actinomycetales
Family Enterobacteriaceae Staphylococcaceae Streptomycetaceae
Genus Escherichia Staphylococcus Streptomyces
Species coli aureus coelicolor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Genus epithet (=species)
Escherichia coli

A

Italicise the name
Escherichia coli
Genus name starts with upper case
A space between genus and species name
Species name starts with lower case

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gram-negatives - proteobacteria

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alphaproteobacteria

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Proteobacteria

A

Alphaproteobacteria : caulobacter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Alphaproteobacteria : Hyphomicrobium

A

Hyphomicrobium cell cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Bacterial life cycle - binary fission vs budding

A

Alphaproteobacteria : diverse positioning of stalks in budding bacteria
Polar - small tail
Sub-polar - long tail
Bi-lateral - two tails either side

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Bacterial diversity proteobacteria

A
  • Alphaproteobacteria : Rizobiales (Agrobacterium, Rizobium)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Proteobacteria - gammaproteobacteria

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Gammaproteobacteria : Pseudomonadales

A

Pseudomonas aeruginosa
Pyoverdine production by Pseudomonas aeruginosa
Biofilm formation of Pseudomonas aeruginosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Enterobacteriales

A

Eschericia coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Proteobacteria - Epsilonproteobacteria

A

Stomach
H.pylori

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Actinobacteria/Firmicutes
26
Gram-positive bacteria
Firmicutes : lactic acid bacteria Lactobacillus delbruekii
27
Lactate fermentation
Glucose —> 2pyruvate —> 2lactate Glycolysis Lactate fermentation
28
Gram-positive bacteria
Firmicutes : endoscope forming bacteria (clostridium, Bacillus)
29
Gram-positive bacteria Firmicutes : endoscope forming bacteria (Clostridium, Bacillus)
Exosporium nap (BcIA) Exosporium basal layer
30
Firmicutes : staphylococcus
|| aureus = purple circles in clumps Staphyloxanthin = beige rounds blobs
31
Hemolysis (=haemolysis)
1. Alpha hemolysis 2. Bete hemolysis 3. Gamma hemolysis
32
Alpha hemolysis (α-hemolysis)
Incomplete / partial hemolysis, green hemolysis Caused by hydrogen peroxide produced by bacteria Oxidising hemoglobin to green methemoglobin
33
Beta hemolysis (β-hemolysis)
Complete hemolysis Caused by enzyme (streptomycin or exotoxin) Produced by bacteria
34
Gamma hemolysis γ-hemolysis
Non-haemolytic
35
Firmicutes : Enterococcus
6 VRE phenotype
36
Actinobacteria
37
Actinobacteria Comparison of microbial genome sizes
Mycoplasma : ~0.6 Mb Bifidobacteria : ~2 Mb staphylococci : 2.8-3 Mb Escherichia : 4.5 - 5 Mb Actinomycetes : 8-9 Mb Yesterday : ~14 Mb
38
Actinobacteria : Corynebacterium
39
Actinobacteria : Mycobacterium
Mycobacterium tuberculosis Complex cell envelope of Mycobacterium
40
Actinomyces
-bovis -israelii
41
Streptomyces
Free spore - germination + growth of substrate mycelium - development of aerial mycelium - growth of an apical aerial hypha - coiling of apical hyphal cell - sporulation-specific septum formation - completion of septation- maturation of spores - dispersal of spores
42
Streptomyces
Spore germination Vegetative growth Substrate mycelium Antibiotic production Formation of reproductive aerial hyphae Aerial hypha Chromosome segregation and separation Spore mutation Spore dispersal
43
- Actinobacteria : Streptomyces (Streptomyces coelicolor)
8,667,507bp
44
Respiratory infections
Streptococcus pneumoniae, Mycobacterium tuberculosis
45
Gastrointestinal infection
Camphylobacter jejuni, salmonella species, Shigella species, Escherichia coli 0157:H7, Helicobacter pylori
46
Skin infection
Enterobacter species, Pseudomonas aeruginosa, Enterococcus species, Staphylococcus species.
47
Upper respiratory trace Nasal cavity Pharynx Larynx
Lower respiratory tract Trachea Primary bronchi Lungs Pneumonia Tuberculosis
48
Pneumonia Fluid filling air space in alveolus Pleurisy Infection irritating pleura (thin outer layer of lung)
Lung inflammation Streptococcus pneumoniae Symp- cough, chest pain, fever, diff breathing Vaccination, various antibiotics
49
Streptococcus pneumoniae
Normal inhabitant of human respiratory tract, causes pneumonia Common cause of bacterial meningitis, ear infections Gram-positive 0.5-1.25 µm in diameter doesn’t form spores, non-motile, alpha hemolytic when cultured on blood agar Encapsulated coccoid bacteria Polysaccharide capsule (virulence factor) 1 cirlcular chromosome = 2 base pairs, GC content of ~40%
50
Streptococcus pneumoniae : antibiotic resistance
1. Commonly used antibiotics : β-lactams (penicillin, amoxicillin, ampicillin) : Cephalosporins (cefotaxime, ceftriaxone) : Macrolides (erythromycin, azithromycin) : Fluroquinolones : Glycopeptides (vancomycin) 2. Antibiotic resistance : Penicillin and Cephalosporins – resistance is common, mediated by altered PBP, transmissible to other pneumococcal strains : Macrolides – efflux pump or ribosomal mutations : Quinolones – efflux pump or DNA gyrase mutations : Vancomycin – no resistance yet
51
Pneumonia vaccine
1. Pneumococcal polysaccharide vaccine (PPV or PPSV) : contains long chains of polysaccharide (sugar) molecules that make up the surface capsule of the bacteria : a pure polysaccharide vaccine induces only short-term immunity and doesn’t work as well in children younger than 2 years : PPSV (Pnuemovax 23 = PPV-23 is known as the latest version) is the first vaccine derived from a capsular polysaccharide : widely used in high-risk adults 2. Pneumococcal conjugate vaccine (PCV) : purified capsular polysaccharides from the bacteria that are "conjugated" (or joined) to a harmless variety of diphtheria toxin : produces an immune response in infants and antibody booster response to multiple doses of vaccine : the British immunisation schedule for infants, with the first dose given at two months old, and is now licensed to protect against invasive disease caused by Streptococcus pneumoniae in adults aged 50 years and older : PCV7, PCV13
52
Tuberculosis (TB)
Attacks lungs Lethal infectious disease caused by mycobacteria Spread through air 1/3 infected 1.3 M deaths 2022 Treatment long course of multiple antibiotics Chronic cough, blood-tinged sputum, fever, night sweats, weight loss
53
Mycobacterium tuberculosis (MTB) Causative agent
-rod-shaped, non-motile, related to actinomycetes -Acid-fast gram-positive or gram-resistant bacteria - waxy coating on cell surface (mycolic acid) = impervious to gram staining -slow growth: divides 15-20 hours -strain variation: significant phenotypic differences between clinical isolates -circular chromosome, GC content 65%: H37Rv strain (4 mega base with 3959 genes) -multi drug-resistant TB (MDR-TB) extensively drug-resistant TB (XDR-TB) major problem
54
Chemotherapy protocol for treatment
Isoniazid Rifampin Pyrazinamide Ethambutol Isoniazid Rifampin
55
Salmonella
Food borne illness: gastroenteritis, typhoid fever, paratyphoid fever -two species, salmonella enterica + salmonella bongori -zoonotic -gram-negative, rod-shaped, non-spore-forming, anaerobic, motile with flagella -0.7-1.5 µm in diameter, 2 - 5 µm in length - chemoorganotrophes : obtaining energy from oxidation and reduction reactions using organic sources - produce hydrogen sulfide
56
Salmonella typhi
Salmonella enterica, serotype Typhi -infects humans only, causes enteric bacterial infection, typhoid fever -symptoms High fever, sweating, diarrhoea, inflammation of stomach /+ intestines. Enlargement of liver + spleen “rose spotted” skin rash on chest + abdomen - 2 million cases, 500,000 deaths -treatment Drug resistance (MDR) -prevention Hygienic life style Vaccines- the live, oral vaccine (Ty21a) + injectable tyhpoid polysaccharide vaccine - 1st genome sequence S. typhi CT18 (MDR) strain 4.8 Mb circular chromosome, 2 plasmids pHCM1 (MRC) + pHCM2
57
Escherichia coli 0157:H7
- Gram-negative, rod shaped bacteria - “O" refers to the cell envelope (LPS) antigen number, "H" refers to the flagella antigen - Enterohemorrhagic E. coli (EHEC) - Shiga-like toxin producing E. coli (STEC) - symptoms of E. coli 0157:H7 infection : a low fever, nausea, vomiting, stomach cramps, and bloody diarrhoea - fatal condition : hemolytic uremic syndrome (HUS) - treatment : non-specific supportive therapy, including hydration, is important : no evidence that treatment with antibiotics is helpful, and taking antibiotics may increase the risk of HUS : antidiarrheal agents such as Imodium should be avoided as it may prolong the duration of the infection
58
Helicobacter pylori
Causes gastritis, gastric ulcers + stomach cancer Helix-shaped, motile, gram-negative, 3 3 µm long with 0.5 µm diameter - genome : 1.6 Mb with 1590 coding genes, 29% of genome is involved in the pathogenesis - virulence of Helicobacter pylori : measured by the ability to produce cotoxin-associated protein (CagA) and active vacuolating cytotoxin (VacA) : Cag pathogenicity island : about 40 Kb long, responsible for pathogenesis, usually absent from H. pylori strains isolated from humans : other important virulent factors - surface-exposed lipopolysaccharide - iron-scavenging system - urease - motility for colonization - type IV secretion system
59
Helicobacter pylori- treatment, prevention + vaccination
- therapy one week ‘triple therapy’ 1 proton pump inhibitor 2 antibiotics - clarithromycin + amoxicillin, || + metronidazole - additional rounds of antibiotic therapy after failure ^ “Quadruple therapy” + bismuth colloid drug Treatment of clarithromycin-resistant H.pylori vaccine levofloxacin -prevention Vaccination Probiotic diet
60
Skin infection Pseudomonas aeruginosa
50% mortality, 4th commonly-isolated nosocomial pathogen -gram-negative, rod-shaped, motile + long monoflagellum -Single cell size 1-5 µm long and 0.5-1.0 µm wide - P. aeruginosa often identified by the production of pyocyanin and fluorescein and ability to grow at 42°C. - pollution control - break down aromatic hydrocarbons - intrinsic resistance to antibiotics P. aeruginosa genome (PA01 strain) : circular form, 6.2 Mb size with ~65% GC content
61
Pseudomonas aeruginosa – biofilm formation
reversible attachment irreversible attachment microcolony formation development of 3-dimensional structure Dispersal
62
Biofilm formation + motility
Swarming Swimming Twitching
63
Pseudomonas aeruginosa – biofilm formation and quorum sensing
N-acyl homoserine lactone
64
Pseudomonas aeruginosa – treatment
-low permeability to antibiotics = resistant - biofilm -s ome antibiotics have shown to be active against P. aeruginosa : aminoglycosides (gentamicin, amikacin, tobramycin) : quinolones (ciprofloxacin, levofloxacin, moxifloxacin) : carbapenems (meropenem, imipenem, doripenem) : polymyxins (polymyxinB, colistin) : monobactams (aztreonam) : cephalosporines (ceftazidime, cefepime, cefoperazone, cefpirome) : antipseudomonal penicillins (ureidopenicillins, carboxypenicillins) - phage therapy combined with antibiotics
65
Enterococcus species
- nosocomial infections - UTI -genus of lactic acid bacteria -tolerant of wide range of environmental conditions 10-45 °C), pH (4.5-10) and high sodium chloride concentrations -common in intestines : Enterococcus faecalis (90-95%), Enterococcus faecium (5-10%) - pathogenicity : cytolysin, a toxin causes rupture of a variety of target membranes, including bacterial cells, erythrocytes, and other mammalian cells - vancomycin resistant enterococcus (VRE)
66
Vancomycin Resistant Enterococcus (VRE)
-1st VRE genome sequence from VanB-type Enterococcus faecalis V583 strain : 1 circular chromosome with 3.2 Mb long (3337 genes), 3 plasmids : more than 25% of total genes are exogenously acquired - 7 integrated phage regions - 38 insertion elements - conjugative and composite transposons - pathogenicity island - vancomycin resistance genes encoded within a previously unknown mobile element in genomic DNA (similar to Tn1549 in other VanB-type E. faecalis) - some other VanA-type VRE carry van resistance allele in plasmid : pIP816 in E. faecium BM4147 - 11 kb long, 9 encoding vancomycin resistance cluster - orf1, orf2, vanR, vanS, vanHAX, vanY, vanZ
67
Staphylococccus species
Greek = bunch of grapes + granule -gram-positive (thicker peptidoglycan cell wall)+ immotile - 40 species -yellow colonies - S. aureus White colonies - S. epidermidis -first genome sequence S. aureus strain NCTC8325 : circular genomic DNA with 2.8 Mb long with 2900 genes. : 33% GC content
68
Staphylococcus aureus
Most common -nosocomial infections, post surgical wound infections -successsful pathogen - immunodeficiency-evasive strategies -emergence of MRSA (Methicillin-Resistant S. aureus) : resistant to almost all clinically available β-lactam antibiotics including penicilins and cephalosporins : vancomycin became the primary antibiotic used to combat MRSA : due to mecA encodes a modified PBP
69
MRSA 1.27 million (direct) 4.95 million (associated)
Drug resistance in six pathogens 929,000 (direct) + 3.57 million (associated) Escherichia coli Staphylococcus aureus Klebsiella pneumoniae Streptococcus pneumoniae Acinetobacter baumannii Pseudomonas aeruginosa MRSA itself > 100,000
70
Pharmageddon?!
71
Staphylococcus aureus :VRSE
Resistant to vancomycin + teicoplanin -acquired VanA type vancomycin resistance genes from VanA-type VRE via horizontal gene - transfer mediated by transposon -antibiotics Trimethoprim/sulfamethoxazole, quinuprisitin/dalfopristin, tigecycline, linezolid and daptomycin - novel antibiotics against VRSA is urgently required
72
Vancomycin resistant MRSA = VRSA (carrying mecA and vanA genes)